We are live on ! Find out more
RMD icon

ResMed
RMD

687 hedge funds and large institutions have $14.3B invested in ResMed in 2023 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 247 increasing their positions, 241 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 74

10% more capital invested

Capital invested by funds: $13B → $14.3B (+$1.25B)

5% more funds holding

Funds holding: 657 → 687 (+30)

2% more repeat investments, than reductions

Existing positions increased: 247 | Existing positions reduced: 241

3.3% less ownership

Funds ownership: 59.67% → 56.37% (-3.3%)

32% less call options, than puts

Call options by funds: $110M | Put options by funds: $162M

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
687
Holders Change
+30
Holders Change %
+4.57%
% of All Funds
10.02%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
112
Increased
247
Reduced
241
Closed
74
Calls
$110M
Puts
$162M
Net Calls
-$52.2M
Net Calls Change
-$73.8M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$178M
2
LCP
LGT Capital Partners
Switzerland
+$105M
3
Fidelity International
Fidelity International
Bermuda
+$91.8M
4
ZIG
Zurich Insurance Group
Switzerland
+$70.3M
5
Jane Street
Jane Street
New York
+$67.2M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$229M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
3
Two Sigma Investments
Two Sigma Investments
New York
-$119M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$101M
5
Marshall Wace
Marshall Wace
United Kingdom
-$96.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
GFPC
676
Global Financial Private Client
Florida
$860 – – –
CSC
677
Caldwell Sutter Capital
California
$860 +$768 +5 New
CAM
678
ClariVest Asset Management
California
$692 -$1.23K -8 -67%
LFG
679
Larson Financial Group
Missouri
$688 +$615 +4 New
PIM
680
Plato Investment Management
Australia
$688 +$615 +4 New
RS
681
Rakuten Securities
Japan
$516 +$461 +3 New
TWD
682
True Wealth Design
Ohio
$345 – – –
EWM
683
Evermay Wealth Management
Virginia
$345 +$307 +2 New
WA
684
WestEnd Advisors
North Carolina
$344 – – –
M
685
MOTCO
Texas
$172 – – –
First Manhattan
686
First Manhattan
New York
$172 +$154 +1 New
DWM
687
Dogwood Wealth Management
Kansas
$4 – – –
Renaissance Technologies
688
Renaissance Technologies
New York
– -$59.9M -405,200 Closed
Capital World Investors
689
Capital World Investors
California
– -$38.9M -263,150 Closed
CFM
690
Capricorn Fund Managers
United Kingdom
– -$34.2M -230,947 Closed
TC
691
TwinBeech Capital
New York
– -$15.6M -105,333 Closed
Capital Fund Management (CFM)
692
Capital Fund Management (CFM)
France
– -$12.2M -79,098 Closed
ACM
693
Aquatic Capital Management
Illinois
– -$11.1M -75,300 Closed
EGM
694
Engineers Gate Manager
New York
– -$9.3M -62,887 Closed
QT
695
Quantbot Technologies
New York
– -$8.76M -59,250 Closed
MGIM
696
M&G Investment Management
United Kingdom
– -$6.03M -40,766 Closed
FIA
697
FNY Investment Advisers
New York
– -$5.06M -34,200 Closed
N
698
Numerai
California
– -$4.59M -31,058 Closed
IIM
699
Intact Investment Management
Quebec, Canada
– -$4.38M -29,600 Closed
FC
700
FORA Capital
Florida
– -$3.71M -25,057 Closed
26 27
28
29 30

RMD Hedge Fund Activity: Q4 2023 in Review

687 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2023, worth a combined $14.3B — up 9.6% from $13B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new RMD positions and 74 closed out — a net gain of 38 holders — while 247 added to existing stakes and 241 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $178M. The largest seller was Citadel Advisors, cutting an estimated $229M.

  • 687 institutional investors held ResMed (RMD) as of Q4 2023, up from 657 in Q3 2023.
  • Funds reported $14.3B of ResMed stock for Q4 2023, up 9.6% quarter-over-quarter.
  • 112 funds opened new ResMed positions in Q4 2023 and 74 closed out, a net change of +38 holders.
  • The largest ResMed buyer in Q4 2023 was Morgan Stanley, an estimated $178M added.
  • The largest ResMed seller in Q4 2023 was Citadel Advisors, an estimated $229M sold.

Based on aggregated 13F filings for Q4 2023.